ret/PTC oncogene expression in papillary thyroid carcinoma

[1]  R. von Wasielewski,et al.  Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts. , 2007, The Journal of surgical research.

[2]  T. Giordano,et al.  HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma. , 2007, Endocrine-related cancer.

[3]  M. Santoro,et al.  RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. , 2006, European journal of endocrinology.

[4]  M. Nikiforova,et al.  Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. , 2006, The Journal of clinical endocrinology and metabolism.

[5]  Y. Nikiforov.  RET/PTC Rearrangement--a link between Hashimoto's thyroiditis and thyroid cancer...or not. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  P. Kastner,et al.  Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.

[7]  M. Kruhøffer,et al.  Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas , 2004, Oncogene.

[8]  D. Noh,et al.  RET Oncogene Expression of Papillary Thyroid Carcinoma in Korea , 2004, Surgery Today.

[9]  G. Chiappetta,et al.  RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. , 2002, The Journal of clinical endocrinology and metabolism.

[10]  Y. Nikiforov.  RET/PTC rearrangement in thyroid tumors , 2002, Endocrine pathology.

[11]  K. Mai,et al.  Hybrid thyroid carcinoma with a coarse chromatin pattern and nuclear features of papillary thyroid carcinoma. , 2002, Pathology, research and practice.

[12]  G. Chiappetta,et al.  RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma. , 2001, European journal of endocrinology.

[13]  C. Cheung,et al.  Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma , 2001, Modern Pathology.

[14]  G. Viglietto,et al.  High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. , 1999, The Journal of clinical endocrinology and metabolism.

[15]  M. Werner,et al.  Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus , 1999, International journal of cancer.

[16]  S. Asa,et al.  Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. , 1998, The Journal of clinical endocrinology and metabolism.

[17]  G. Chiappetta,et al.  RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  A. Bounacer,et al.  High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation , 1997, Oncogene.

[19]  S. Asa,et al.  ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? , 1996, The Journal of clinical endocrinology and metabolism.

[20]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[21]  T. Ishikawa,et al.  Expression of the ret proto‐oncogene product in human normal and neoplastic tissues of neural crest origin , 1994, The Journal of pathology.

[22]  M. Santoro,et al.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases , 1987, Nature.